TMC 114 and 125 experimental drugs to be tested on four HIV patients

by Medindia Content Team on  January 15, 2006 at 2:49 PM Drug News   - G J E 4
TMC 114 and 125 experimental drugs to be tested on four HIV patients
Four HIV patients who have found resistant to most of the HIV drugs in the city of Vancouver in British Columbia would be given the experimental drugs TMC 114 and TMC 125 as a last hope to save their lives. Though clinical trials with experimental drugs are undertaken under strict protocols this study is tested on a hope to find a cure and save the lives of these four HIV patients.

TMC 125 is Non-nucleoside reverse transcriptase inhibitor, which has found to have high potency of 98% inhibition HIV. The TMC 125 drug was found effective in a study in which patients were found resistant to nevirapine. TMC 114 is a HIV protease inhibitor, which is found to be an analogue to TMC 126 and is found to be effective in reducing HIV virus burden.

These clinical trials are conducted in these four patients who had shown resistance to most of the anti-retroviral drugs. These experimental clinical trials will be conducted after ethical clearance and institutional review clearance.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like